NET INCOME PER SHARE

6 Months Ended

Jun. 30, 2013

Net Income Loss Per Share Disclosure [Abstract]

NET INCOME PER SHARE

NOTE 15 – NET INCOMEPER SHARE

The following table sets forth the computation of basic and diluted net income per share for the periods indicated:

	For the three months ended
	June 30, 2013		June 30, 2012
	USD		USD
Net income attributable to China Biologic Products, Inc.		16,161,926		12,838,771
Earnings allocated to participating nonvested shares		(85,227)		-
Net income allocated to common stockholders used in computing basic net     income per common stock		16,076,699		12,838,771
Change in fair value of warrants		-		(559,758)
Net income used in diluted net income per common stock		16,076,699		12,279,013
Weighted average shares used in computing basic net income per common stock		26,880,459		25,875,164
Diluted effect of warrants		-		311,200
Diluted effect of stock option		1,186,844		440,796
Weighted average shares used in computing diluted net income per common stock		28,067,303		26,627,160
Net income per common stock – basic		0.60		0.50
Net income per common stock – diluted		0.57		0.46

During the three months ended June 30, 2013, no option was antidilutive and excluded from the calculation of diluted net income per common stock.

During the three months ended June 30, 2012, 1,544,000 options with an average exercise price of $11.98 were excluded from the calculation of diluted net income per common stock since they were antidilutive.

The following table sets forth the computation of basic and diluted net income per share for the periods indicated:

	For the six months ended
	June 30, 2013		June 30, 2012
	USD		USD
Net income attributable to China Biologic Products, Inc.		31,077,786		25,796,077
Earnings allocated to participating nonvested shares		(157,615)		-
Net income allocated to common stockholders used in computing basic net income per common stock		30,920,171		25,796,077
Change in fair value of warrants		-		(1,769,140)
Net income used in diluted net income per common stock		30,920,171		24,026,937
Weighted average shares used in computing basic net income per common stock		26,833,262		25,738,145
Diluted effect of warrants		-		390,507
Diluted effect of stock option		1,133,818		453,172
Weighted average shares used in computing diluted net income per common stock		27,967,080		26,581,824
Net income per common stock – basic		1.15		1.00
Net income per common stock – diluted		1.11		0.90

During the six months ended June 30, 2013, no option was antidilutive and excluded from the calculation of diluted net income per common stock.

During the six months ended June 30, 2012, 1,544,000 options with an average exercise price of $11.98 were excluded from the calculation of diluted net income per common stock since they were antidilutive.